Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Mobile clinic and village doctors screening for heart failure in rural atrial fibrillation

Tests mobile clinic screening and village doctor care for heart failure in atrial fibrillation.

Key facts

Who runs it
Jiangsu Taizhou People's Hospital
Where
Lianyungang, ChinaSee the site
Trial code
Registry title
Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
Status
Not yet recruiting
People taking part
1,200 people, planned
Started
10 Oct 2026
Expected to end
30 Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care Group
  • Routine Management Group
Record updated
27 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 65 and over with atrial fibrillation who live in Donghai County, China, and are looked after by a village clinic.

Age
65 years or older
Sex
All sexes
Disease stage
Atrial fibrillation confirmed by an electrocardiogram (ECG) or by a specialist's diagnostic certificate.

Main reasons for not taking part

  • Expected life expectancy of less than 3 months
  • Severe kidney problems (Ccr < 30ml/min) or ongoing dialysis
  • Heart failure caused by a correctable cause, such as an overactive thyroid, anemia or an uncorrected congenital heart defect
  • Needs a pacemaker but has not had one implanted
  • COPD with type II respiratory failure

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Permanent residents with local household registration at the primary level in Donghai County, aged ≥ 65 years
  • Electrocardiogram (ECG) confirmation of AF or possession of a diagnostic certificate for AF issued by a specialist
  • Management by a village clinic near the participant's place of residence
  • Ability to understand the study procedures and provide written informed consent

Who cannot take part

  • Severe renal insufficiency (Ccr < 30ml/min) or ongoing dialysis treatment
  • Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease
  • Chronic obstructive pulmonary disease (COPD) complicated by type II respiratory failure
  • Special populations, including patients with mental illnesses
  • Expected life expectancy of less than 3 months
  • Indications for pacemaker implantation without having undergone implantation

Where in China

  • Donghai County People's HospitalLianyungang, ChinaContact: Hongmei ZhouNo longer taking part

About the trial

What the trial wants to find out

AF and HF frequently coexist and are associated with poor clinical outcomes. In rural areas, limited access to echocardiography, NT-proBNP testing, and specialist care may hinder the early identification and appropriate management of HF among patients with AF. Mobile clinics may help overcome these barriers by bringing diagnostic testing and specialist support directly to rural communities.

Read full original descriptionShow less

This cluster-randomized controlled trial aims to evaluate a mobile clinic-supported, village doctor-led model for HF screening and integrated management among older patients with AF in rural China. Mobile clinics equipped with echocardiography and NT-proBNP testing will support HF screening, and subsequent management will be tailored according to HF status. The study will evaluate whether this model can improve the detection of HF and reduce adverse cardiovascular events compared with routine management.

The 2 groups in the trial

  • Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care GroupTreatment being tested

    Participants in this group will receive mobile clinic-supported, village doctor-led integrated management. Mobile clinics equipped with echocardiography and NT-proBNP testing will provide HF screening for patients with AF. Based on HF status, village doctors and specialists will provide stratified management, including AF management according to the ABC pathway and optimization of guideline-directed medical therapy for HF when appropriate. Specialist-supported mobile clinics will provide regular assessment and medication adjustment (once every 3 months), while village doctors will conduct ongoing follow-up and health management.

  • Routine Management GroupExisting treatment, for comparison

    Participants in this group will receive routine chronic disease management according to the National Basic Public Health Service standards. Village doctors will provide regular follow-up, general health education, medication documentation, and routine referral services. Participants will not receive mobile clinic-supported HF screening or the structured guideline-based management provided to the intervention group.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
Plain-language title
Mobile clinic and village doctors screening for heart failure in rural atrial fibrillationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
27 October 2026